EFSA concluded BLS’ core ingredient D-Ribose is safe for the general population including children. The evaluation relates to a value of 36 mg/kg/day, which for a 70Kg adult is equivalent to a daily dosage of 2.5g, which is a strong dose for efficacy, according to the company.
“We have worked very hard for this achievement and are very happy we have the safety approval from EFSA to use Bioenergy Ribose in food and beverage applications in the EU,” stated Marianne McDonagh, vice president of sales at BLS.
Bioenergy Ribose has been used in dietary supplements for nearly 30 years in Europe. Its use in the U.S., where it is FDA GRAS-certified, extends over 40 years and includes sports nutrition and functional food and beverage applications. Its health enhancing benefits have been experienced by millions of users.
“We look forward to continue working with the EU Commission to define the list of food categories and expanding our brand and core product, Bioenergy Ribose, in Europe,” said Ms. McDonagh.
For the complete report, please follow this link: http://www.efsa.europa.eu/en/efsajournal/pub/5265